These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 1656049)
1. X-ray structure of human relaxin at 1.5 A. Comparison to insulin and implications for receptor binding determinants. Eigenbrot C; Randal M; Quan C; Burnier J; O'Connell L; Rinderknecht E; Kossiakoff AA J Mol Biol; 1991 Sep; 221(1):15-21. PubMed ID: 1656049 [TBL] [Abstract][Full Text] [Related]
2. Introduction of relaxin properties into other hormones of insulin-like structure. Büllesbach EE; Schwabe C SAAS Bull Biochem Biotechnol; 1996; 9():63-8. PubMed ID: 8652134 [TBL] [Abstract][Full Text] [Related]
3. Structure of human insulin-like peptide 5 and characterization of conserved hydrogen bonds and electrostatic interactions within the relaxin framework. Haugaard-Jönsson LM; Hossain MA; Daly NL; Craik DJ; Wade JD; Rosengren KJ Biochem J; 2009 May; 419(3):619-27. PubMed ID: 19178384 [TBL] [Abstract][Full Text] [Related]
4. Relaxin-3, INSL5, and their receptors. Liu C; Lovenberg TW Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022 [TBL] [Abstract][Full Text] [Related]
5. Identification of the receptor-recognition surface of bombyxin-II, an insulin-like peptide of the silkmoth Bombyx mori: critical importance of the B-chain central part. Nagata K; Hatanaka H; Kohda D; Kataoka H; Nagasawa H; Isogai A; Ishizaki H; Suzuki A; Inagaki F J Mol Biol; 1995 Nov; 253(5):759-70. PubMed ID: 7473750 [TBL] [Abstract][Full Text] [Related]
6. Structural basis of allosteric ligand-receptor interactions in the insulin/relaxin peptide family: implications for other receptor tyrosine kinases and G-protein-coupled receptors. De Meyts P; Gauguin L; Svendsen AM; Sarhan M; Knudsen L; Nøhr J; Kiselyov VV Ann N Y Acad Sci; 2009 Apr; 1160():45-53. PubMed ID: 19416158 [TBL] [Abstract][Full Text] [Related]
7. Three-dimensional solution structure of bombyxin-II an insulin-like peptide of the silkmoth Bombyx mori: structural comparison with insulin and relaxin. Nagata K; Hatanaka H; Kohda D; Kataoka H; Nagasawa H; Isogai A; Ishizaki H; Suzuki A; Inagaki F J Mol Biol; 1995 Nov; 253(5):749-58. PubMed ID: 7473749 [TBL] [Abstract][Full Text] [Related]
8. Structure and activity in the relaxin family of peptides. Tregear GW; Bathgate RA; Hossain MA; Lin F; Zhang S; Shabanpoor F; Scott DJ; Ma S; Gundlach AL; Samuel CS; Wade JD Ann N Y Acad Sci; 2009 Apr; 1160():5-10. PubMed ID: 19416150 [TBL] [Abstract][Full Text] [Related]
9. Ligand-induced activation of the insulin receptor: a multi-step process involving structural changes in both the ligand and the receptor. Ward CW; Lawrence MC Bioessays; 2009 Apr; 31(4):422-34. PubMed ID: 19274663 [TBL] [Abstract][Full Text] [Related]
10. Structural insights into the function of relaxins. Rosengren KJ; Bathgate RA; Craik DJ; Daly NL; Haugaard-Jönsson LM; Hossain MA; Wade JD Ann N Y Acad Sci; 2009 Apr; 1160():20-6. PubMed ID: 19416153 [TBL] [Abstract][Full Text] [Related]
11. Negative cooperativity in H2 relaxin binding to a dimeric relaxin family peptide receptor 1. Svendsen AM; Zalesko A; Kønig J; Vrecl M; Heding A; Kristensen JB; Wade JD; Bathgate RA; De Meyts P; Nøhr J Mol Cell Endocrinol; 2008 Dec; 296(1-2):10-7. PubMed ID: 18723073 [TBL] [Abstract][Full Text] [Related]
12. Synthetic human insulin 4 does not activate the G-protein-coupled receptors LGR7 or LGR8. Lin F; Otvos L; Kumagai J; Tregear GW; Bathgate RA; Wade JD J Pept Sci; 2004 May; 10(5):257-64. PubMed ID: 15160837 [TBL] [Abstract][Full Text] [Related]
13. Probing the functional domains of relaxin-3 and the creation of a selective antagonist for RXFP3/GPCR135 over relaxin receptor RXFP1/LGR7. Liu C; Kuei C; Sutton S; Shelton J; Zhu J; Nepomuceno D; Hossain MA; Wade JD; Bathgate RA; Bonaventure P; Lovenberg T Ann N Y Acad Sci; 2009 Apr; 1160():31-7. PubMed ID: 19416155 [TBL] [Abstract][Full Text] [Related]
14. Comparison of relaxin receptors in rat isolated atria and uterus by use of synthetic and native relaxin analogues. Tan YY; Wade JD; Tregear GW; Summers RJ Br J Pharmacol; 1998 Feb; 123(4):762-70. PubMed ID: 9517397 [TBL] [Abstract][Full Text] [Related]
15. Mouse relaxin: synthesis and biological activity of the first relaxin with an unusual crosslinking pattern. Büllesbach EE; Schwabe C Biochem Biophys Res Commun; 1993 Oct; 196(1):311-9. PubMed ID: 8216305 [TBL] [Abstract][Full Text] [Related]
16. Identification of important residues of insulin-like peptide 5 and its receptor RXFP4 for ligand-receptor interactions. Wang XY; Guo YQ; Shao XX; Liu YL; Xu ZG; Guo ZY Arch Biochem Biophys; 2014 Sep; 558():127-32. PubMed ID: 25043977 [TBL] [Abstract][Full Text] [Related]
17. Modeling the primary hormone-binding site of RXFP1 and RXFP2. Scott DJ; Tregear GW; Bathgate RA Ann N Y Acad Sci; 2009 Apr; 1160():74-7. PubMed ID: 19416162 [TBL] [Abstract][Full Text] [Related]
18. Multiple binding sites revealed by interaction of relaxin family peptides with native and chimeric relaxin family peptide receptors 1 and 2 (LGR7 and LGR8). Halls ML; Bond CP; Sudo S; Kumagai J; Ferraro T; Layfield S; Bathgate RA; Summers RJ J Pharmacol Exp Ther; 2005 May; 313(2):677-87. PubMed ID: 15649866 [TBL] [Abstract][Full Text] [Related]
19. International Union of Pharmacology LVII: recommendations for the nomenclature of receptors for relaxin family peptides. Bathgate RA; Ivell R; Sanborn BM; Sherwood OD; Summers RJ Pharmacol Rev; 2006 Mar; 58(1):7-31. PubMed ID: 16507880 [TBL] [Abstract][Full Text] [Related]
20. The expression of human relaxin in yeast. Yang S; Heyn H; Zhang YZ; Büllesbach EE; Schwabe C Arch Biochem Biophys; 1993 Feb; 300(2):734-7. PubMed ID: 8382033 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]